Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Check-Cap Ltd. stock logo
CHEK
Check-Cap
$0.74
+0.2%
$0.80
$0.56
$3.04
$4.31M0.22378,873 shs15,734 shs
Lifeward Ltd. stock logo
LFWD
Lifeward
$1.03
-3.7%
$1.30
$1.00
$4.77
$11.78M0.16696,231 shs146,552 shs
NeurAxis, Inc. stock logo
NRXS
NeurAxis
$2.54
$2.42
$1.33
$6.20
$18.33M3.34417,934 shs126,026 shs
Beyond Air, Inc. stock logo
XAIR
Beyond Air
$0.23
+14.6%
$0.20
$0.16
$1.49
$17.47M0.231.57 million shs18.97 million shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Check-Cap Ltd. stock logo
CHEK
Check-Cap
-2.06%-1.14%-16.17%-15.99%-66.28%
Lifeward Ltd. stock logo
LFWD
Lifeward
-3.74%-6.36%-13.45%-40.12%-75.53%
NeurAxis, Inc. stock logo
NRXS
NeurAxis
0.00%+10.92%-20.63%+9.96%-9.29%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
+14.58%+30.30%+26.05%-13.57%-81.60%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Check-Cap Ltd. stock logo
CHEK
Check-Cap
0.4479 of 5 stars
0.05.00.00.00.00.00.6
Lifeward Ltd. stock logo
LFWD
Lifeward
2.0897 of 5 stars
3.53.00.00.00.80.01.3
NeurAxis, Inc. stock logo
NRXS
NeurAxis
2.8955 of 5 stars
3.53.00.00.02.83.30.0
Beyond Air, Inc. stock logo
XAIR
Beyond Air
4.2267 of 5 stars
3.54.00.03.52.00.81.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Check-Cap Ltd. stock logo
CHEK
Check-Cap
0.00
N/AN/AN/A
Lifeward Ltd. stock logo
LFWD
Lifeward
3.00
Buy$9.00773.79% Upside
NeurAxis, Inc. stock logo
NRXS
NeurAxis
3.00
Buy$7.00175.59% Upside
Beyond Air, Inc. stock logo
XAIR
Beyond Air
3.00
Buy$1.50547.11% Upside

Current Analyst Ratings Breakdown

Latest CHEK, NRXS, XAIR, and LFWD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/16/2025
NeurAxis, Inc. stock logo
NRXS
NeurAxis
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
6/16/2025
NeurAxis, Inc. stock logo
NRXS
NeurAxis
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy$7.00
(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Check-Cap Ltd. stock logo
CHEK
Check-Cap
N/AN/AN/AN/A$4.05 per shareN/A
Lifeward Ltd. stock logo
LFWD
Lifeward
$25.66M0.44N/AN/A$2.14 per share0.48
NeurAxis, Inc. stock logo
NRXS
NeurAxis
$2.93M6.24N/AN/A($0.27) per share-9.41
Beyond Air, Inc. stock logo
XAIR
Beyond Air
$3.70M5.41N/AN/A$0.75 per share0.31
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Check-Cap Ltd. stock logo
CHEK
Check-Cap
-$17.57M-$3.00N/AN/AN/AN/AN/AN/A
Lifeward Ltd. stock logo
LFWD
Lifeward
-$28.94M-$3.04N/AN/AN/A-108.21%-101.96%-70.49%8/13/2025 (Estimated)
NeurAxis, Inc. stock logo
NRXS
NeurAxis
-$14.63M-$1.19N/AN/A-492.76%N/A-641.25%N/A
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-$60.24M-$1.06N/AN/AN/A-1,258.46%-213.97%-104.66%8/5/2025 (Estimated)

Latest CHEK, NRXS, XAIR, and LFWD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/17/2025Q4 2025
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-$0.14-$0.09+$0.05-$0.09$1.39 million$1.15 million
5/15/2025Q1 2025
Lifeward Ltd. stock logo
LFWD
Lifeward
-$0.33-$0.46-$0.13-$0.46$5.84 million$5.03 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Check-Cap Ltd. stock logo
CHEK
Check-Cap
N/AN/AN/AN/AN/A
Lifeward Ltd. stock logo
LFWD
Lifeward
N/AN/AN/AN/AN/A
NeurAxis, Inc. stock logo
NRXS
NeurAxis
N/AN/AN/AN/AN/A
Beyond Air, Inc. stock logo
XAIR
Beyond Air
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Check-Cap Ltd. stock logo
CHEK
Check-Cap
N/AN/AN/A
Lifeward Ltd. stock logo
LFWD
Lifeward
N/A
2.18
1.43
NeurAxis, Inc. stock logo
NRXS
NeurAxis
N/A
0.24
0.23
Beyond Air, Inc. stock logo
XAIR
Beyond Air
N/A
3.56
3.12

Institutional Ownership

CompanyInstitutional Ownership
Check-Cap Ltd. stock logo
CHEK
Check-Cap
1.07%
Lifeward Ltd. stock logo
LFWD
Lifeward
26.76%
NeurAxis, Inc. stock logo
NRXS
NeurAxis
11.77%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
31.50%

Insider Ownership

CompanyInsider Ownership
Check-Cap Ltd. stock logo
CHEK
Check-Cap
0.48%
Lifeward Ltd. stock logo
LFWD
Lifeward
2.50%
NeurAxis, Inc. stock logo
NRXS
NeurAxis
26.40%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
19.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Check-Cap Ltd. stock logo
CHEK
Check-Cap
805.85 million5.82 millionNot Optionable
Lifeward Ltd. stock logo
LFWD
Lifeward
6011.01 million10.73 millionOptionable
NeurAxis, Inc. stock logo
NRXS
NeurAxis
197.22 million6.09 millionNot Optionable
Beyond Air, Inc. stock logo
XAIR
Beyond Air
7086.37 million69.61 millionOptionable

Recent News About These Companies

FY2029 EPS Estimates for Beyond Air Lifted by Roth Capital
Beyond Air granted U.S. patent for gaseous nitric oxide delivery
Beyond Air Gets Patent for Lung Infection Treatment

New MarketBeat Followers Over Time

Media Sentiment Over Time

Check-Cap stock logo

Check-Cap NASDAQ:CHEK

$0.74 +0.00 (+0.20%)
Closing price 06/20/2025 03:52 PM Eastern
Extended Trading
$0.74 0.00 (-0.47%)
As of 06/20/2025 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.

Lifeward stock logo

Lifeward NASDAQ:LFWD

$1.03 -0.04 (-3.74%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$1.07 +0.04 (+4.27%)
As of 06/20/2025 06:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

NeurAxis stock logo

NeurAxis NASDAQ:NRXS

$2.54 0.00 (0.00%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$2.52 -0.02 (-0.94%)
As of 06/20/2025 06:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

Beyond Air stock logo

Beyond Air NASDAQ:XAIR

$0.23 +0.03 (+14.58%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$0.22 -0.01 (-4.66%)
As of 06/20/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.